drugset / Trial / NCT02262156

CBT Versus Selective Serotonin Reuptake Inhibitor For Treatment Of Depression In Temporal Lobe Epilepsy Patients

NCT02262156

Non-randomizedParallel-groupSingle-blindTreatment

Summary

The aim of the study is to compare the effect of group-cognitive-behavioral therapy (CBT)versus treatment as usual with the selective serotonin reuptake inhibitor sertraline, in patients with diagnosis of temporal lobe epilepsy (TLE) and depressive disorder.

Timeline

Start
2014-08
Primary completion
2014-10
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Citalopram Small molecule
Comparator Sertraline Small molecule